Lupin inaugurates Atharv Ability, an advanced multidisciplinary neuro-rehabilitation center in Delhi
Global pharma major Lupin announced the launch of Atharv Ability, its world-class neuro-rehabilitation center in Naraina Vihar,…
Author
Indulekha Bringha Hair Growth Serum completes second clinical trial
Indulekha has announced the successful completion of its second large clinical study on the Indulekha Bringha Hair Growth Serum,…
Indoco Remedies clears Malta Medicines Authority audit
The facility has received EU GMP certification from the Malta Medicines Authority confirming that it complies with the Good…
Zydus to acquire Assertio in all-cash tender offer
Assertio is focused on specialty and oncology supportive-care therapies
Lupin gets US FDA nod for Famotidine Injection, USP
This product would be manufactured at Lupin’s Nagpur facility in India
Lilly launches Lormalzi for treatment of early symptomatic Alzheimer’s Disease in India
Eli Lilly and Company (India) announced the launch of Lormalzi (donanemab, 350 mg/20 mL IV vial) in India, following marketing…
AstraZeneca launches K+ Connect to advance hyperkalemia management in heart failure, chronic kidney…
AstraZeneca Pharma India has launched K+ Connect, a pan-India multidisciplinary initiative focused on advancing the management of…
Agilent and Veeda Lifesciences launch Joint Analytical Center of Excellence to accelerate GLP‑1,…
Agilent Technologies, a global leader in analytical and laboratory solutions, today announced a strategic collaboration with Veeda…
Patent pause: Link extensions to pendency
India is now well-positioned to introduce a limited, risk-calibrated patent-term extension (PTE) mechanism tailored to Active…
SwishX launches world’s first agentic AI platform for pharma and medtech
SwishX announced its launch, introducing the World’s first Agentic AI platform built exclusively for pharmaceutical and medtech…